Gender differences in hepatitis C antibody prevalence and risk behaviours amongst people who inject drugs in Australia 1998-2008.

@article{Iversen2010GenderDI,
  title={Gender differences in hepatitis C antibody prevalence and risk behaviours amongst people who inject drugs in Australia 1998-2008.},
  author={Jenny Iversen and Handan Wand and Andrea Gonnermann and Lisa Maher},
  journal={The International journal on drug policy},
  year={2010},
  volume={21 6},
  pages={471-6}
}
BACKGROUND Global prevalence of hepatitis C virus (HCV) is estimated to be around 3% with approximately 170 million people affected. In Australia, and in many other resource rich countries, injecting drug use is the single most important risk factor for acquiring HCV, with around a third of diagnoses occurring in women. This study aims to assess gender… CONTINUE READING